A plain-language guide · The US position
What does the US record actually say?
If an offer points to an FDA database, it can look like permission. Before treating that as an answer, find out what kind of record it is.
There is no US approval to point to
Selank lacked both FDA drug approval and an official US drug label as of September 30, 2026.
On that same check, the US drug-code entries for Selank were raw ingredient powders, rather than finished medicines.
A drug code points to a listed entry; that entry gives no assurance of FDA product approval.
A withdrawn request is not permission
A pharmacist or doctor can tailor a medicine to one patient’s needs; this preparation is called compounding.
A request to consider Selank for pharmacy use appears on the FDA page, which was current as of April 22, 2026. The people or groups who submitted it took it back.
The FDA still warns that information about harm from Selank in people is missing. Taking back the request did not give pharmacies permission to use it.
As of September 30, 2026, Selank was missing from the legal list of extra pharmacy ingredients and from the FDA’s temporary review groups.
Our interpretation as of September 26, 2026 is that these rules prevent an ordinary pharmacy from legally making a patient’s Selank medicine.
If a service proposes Selank, ask: which law allows you to provide this exact product to me? A database screenshot does not answer that question.
Russia does not settle the US question
Selank was registered as a medicine in Russia. The information checked September 30, 2026 did not confirm whether Russia still allowed it.
That history does not create US approval.
Treat an answer about another country as an answer about that country. Bring the conversation back to the product and care being offered to you here.
Open the sources for this page
Source checks behind these answers: September 17, 2026; September 26, 2026; September 30, 2026.
- FDA application search for Selank
Use this FDA search to check whether a Selank medicine has US approval.
- FDA ingredient listings for Selank
These listings are for ingredient powders, not ready-made medicines; a listing does not mean FDA approval.
- FDA withdrawn-request entry
The FDA still reports missing information about harm from Selank; taking back a request for pharmacy use did not resolve those concerns.
- Federal pharmacy ingredient list
Selank was not on this list of extra ingredients pharmacies may use, as checked September 30, 2026.
- FDA pharmacy category document
Selank was in none of these FDA pharmacy-ingredient groups as of September 30, 2026.
- FDA facility category document
This FDA list is for larger facilities that make medicines to order; Selank was absent as of September 30, 2026.
- FDA guide to pharmacy ingredient rules
This explains the rules for pharmacy ingredients and when the FDA may temporarily hold off taking action; that pause is not permission to use Selank.